Thank you ILT. Your post aligns with the very recent Gemini's correction regarding MAA's approval.
Not more than two weeks ago this AI told me to expect MHRA's decision in May or less likely in June. A few minutes ago, their prediction of MHRA's decision was postponed to June or even beyond. Their explanation was that apparently prior to the acquisition of Welbeck's leukapheresis center, approval depended only on regulatory compliance but as of April 21 (acquisition of the Welbeck Center), an increase of commercial capabilities was added to the approval requirement. While after approval we can expect a much more robust initial commercial launch, it may significantly increase the time to approval.
Hoping very much for an approval in June and maybe this upcoming 10-Q will tell us how soon we can expect the Grade C suite(s) and Flaskworks to be ready for action.
Bullish